Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy.

By Alexandra F. Santos. New England Journal of Medicine, 2016

1,104 citations recorded by the source corpus.

OF THE

Subfields: Epidemiology, Immunology and Allergy, Pharmacy

View Paper: https://www.semanticscholar.org/paper/7bed11406d35f6d99f483ba9e037b5d124767b4d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. S. Sicherer
2. Hugh A. Sampson

In Immunology and Allergy

1. S. Sicherer
2. Hugh A. Sampson

In Pharmacy

1. S. Sicherer
2. Hugh A. Sampson

Citations in the corpus

• Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. (2018, background): “In the Learning Early About Peanut (LEAP) trial, infants aged 4 to 11 months at high risk (severe eczema and or egg allergy) for peanut allergy but with peanut SPTwheals of 4 mm or less were randomized to consume or avoid peanut to age 5 years.(56) Those who were sensitized to peanut and randomized ”